Inventor
HOLERS V MICHAEL
US21 patents
⚠️ This page may combine multiple inventors who share the name “HOLERS V MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV COLORADO REGENTS
8 patentsUS10233235B2Mar 19, 2019
Modulating the alternative complement pathway
UNIV COLORADO REGENTS1 citations72
US9259488B2Feb 16, 2016
Anti-C3d antibody conjugates and methods of detecting complement activation
UNIV COLORADO REGENTS4 citations70
US11407820B2Aug 9, 2022
Modulating the alternative complement pathway
UNIV COLORADO REGENTS0 citations61
USRE49339EDec 20, 2022
Antibodies to the C3D fragment of complement component 3
UNIV COLORADO REGENTS0 citations60
US9212212B2Dec 15, 2015
Targeting complement factor H for treatment of diseases
UNIV COLORADO REGENTS1 citations60
US10278986B2May 7, 2019
Antibody-siRNA conjugates and uses therefor
UNIV COLORADO REGENTS1 citations53
US8858945B2Oct 14, 2014
Three-dimensional structure of complement receptor type 2 and uses thereof
UNIV COLORADO REGENTS0 citations51
US10413620B2Sep 17, 2019
Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
UNIV COLORADO REGENTS0 citations49
HOLERS V MICHAEL
3 patentsUS9815890B2Nov 14, 2017
Antibodies to the C3d fragment of complement component 3
HOLERS V MICHAEL7 citations79
US8703140B2Apr 22, 2014
Inhibition of factor B, the alternative complement pathway and methods related thereto
HOLERS V MICHAEL2 citations58
US10239937B2Mar 26, 2019
Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis
HOLERS V MICHAEL1 citations51